Caricamento...
Insights into Chagas treatment based on the potential of bacteriocin AS-48
Chagas disease caused by the protozoan parasite Trypanosoma cruzi represents a significant public health problem in Latin America, affecting around 8 million cases worldwide. Nowadays is urgent the identification of new antichagasic agents as the only therapeutic options available, Nifurtimox and Be...
Salvato in:
| Pubblicato in: | Int J Parasitol Drugs Drug Resist |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6447751/ https://ncbi.nlm.nih.gov/pubmed/30953804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2019.03.003 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|